The Economics of Brain Metastases View Full Text


Ontology type: schema:Chapter     


Chapter Info

DATE

2007

AUTHORS

Charles L. Bennett , Cara C. Tigue , Karen A. Fitzner

ABSTRACT

Brain metastases represent a significant healthcare problem, with almost 200,000 patients in the United States annually suffering from symptomatic parenchymal lesions. Lung, breast, melanoma, renal, and gastrointestinal cancers make up most of the clinically relevant lesions. Although median survival once brain metastases are diagnosed is less than a year, timely therapy can restore neurological function and can prevent further neurological complications for the duration of a patient’s survival. Important prognostic features include absence of extracranial disease progression, young age, high pretreatment neurological status, a low number of lesions, and a long interval from primary disease diagnosis to the development of brain metastases. More... »

PAGES

23-29

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/978-0-387-69222-7_2

DOI

http://dx.doi.org/10.1007/978-0-387-69222-7_2

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1036846740

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/18078263


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1109", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Neurosciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Brain Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Radiosurgery", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Division of Hematology/Oncology Feinberg School of Medicine The Robert H. Lurie Comprehensive Cancer Center, Northwestern University, 60611, Chicago, IL, USA", 
          "id": "http://www.grid.ac/institutes/grid.16753.36", 
          "name": [
            "Division of Hematology/Oncology Feinberg School of Medicine The Robert H. Lurie Comprehensive Cancer Center, Northwestern University, 60611, Chicago, IL, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Bennett", 
        "givenName": "Charles L.", 
        "id": "sg:person.01100705232.37", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01100705232.37"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Division of Hematology/Oncology Feinberg School of Medicine The Robert H. Lurie Comprehensive Cancer Center, Northwestern University, 60611, Chicago, IL, USA", 
          "id": "http://www.grid.ac/institutes/grid.16753.36", 
          "name": [
            "Division of Hematology/Oncology Feinberg School of Medicine The Robert H. Lurie Comprehensive Cancer Center, Northwestern University, 60611, Chicago, IL, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Tigue", 
        "givenName": "Cara C.", 
        "id": "sg:person.013156761617.16", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013156761617.16"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Division of Hematology/Oncology Feinberg School of Medicine The Robert H. Lurie Comprehensive Cancer Center, Northwestern University, 60611, Chicago, IL, USA", 
          "id": "http://www.grid.ac/institutes/grid.16753.36", 
          "name": [
            "Division of Hematology/Oncology Feinberg School of Medicine The Robert H. Lurie Comprehensive Cancer Center, Northwestern University, 60611, Chicago, IL, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Fitzner", 
        "givenName": "Karen A.", 
        "id": "sg:person.01220574267.85", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01220574267.85"
        ], 
        "type": "Person"
      }
    ], 
    "datePublished": "2007", 
    "datePublishedReg": "2007-01-01", 
    "description": "Brain metastases represent a significant healthcare problem, with almost 200,000 patients in the United States annually suffering from symptomatic parenchymal lesions. Lung, breast, melanoma, renal, and gastrointestinal cancers make up most of the clinically relevant lesions. Although median survival once brain metastases are diagnosed is less than a year, timely therapy can restore neurological function and can prevent further neurological complications for the duration of a patient\u2019s survival. Important prognostic features include absence of extracranial disease progression, young age, high pretreatment neurological status, a low number of lesions, and a long interval from primary disease diagnosis to the development of brain metastases.", 
    "editor": [
      {
        "familyName": "Raizer", 
        "givenName": "Jeffrey J.", 
        "type": "Person"
      }, 
      {
        "familyName": "Abrey", 
        "givenName": "Lauren E.", 
        "type": "Person"
      }
    ], 
    "genre": "chapter", 
    "id": "sg:pub.10.1007/978-0-387-69222-7_2", 
    "isAccessibleForFree": false, 
    "isPartOf": {
      "isbn": [
        "978-0-387-69221-0", 
        "978-0-387-69222-7"
      ], 
      "name": "Brain Metastases", 
      "type": "Book"
    }, 
    "keywords": [
      "brain metastases", 
      "further neurological complications", 
      "extracranial disease progression", 
      "primary disease diagnosis", 
      "important prognostic features", 
      "significant healthcare problem", 
      "neurological complications", 
      "median survival", 
      "neurological status", 
      "parenchymal lesions", 
      "prognostic features", 
      "neurological function", 
      "patient survival", 
      "disease progression", 
      "gastrointestinal cancer", 
      "timely therapy", 
      "relevant lesions", 
      "younger age", 
      "metastasis", 
      "healthcare problem", 
      "lesions", 
      "survival", 
      "longer intervals", 
      "disease diagnosis", 
      "low number", 
      "complications", 
      "patients", 
      "lung", 
      "therapy", 
      "breast", 
      "cancer", 
      "melanoma", 
      "diagnosis", 
      "progression", 
      "age", 
      "United States", 
      "duration", 
      "status", 
      "years", 
      "intervals", 
      "absence", 
      "function", 
      "development", 
      "number", 
      "features", 
      "state", 
      "problem", 
      "economics", 
      "symptomatic parenchymal lesions", 
      "high pretreatment neurological status", 
      "pretreatment neurological status"
    ], 
    "name": "The Economics of Brain Metastases", 
    "pagination": "23-29", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1036846740"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/978-0-387-69222-7_2"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "18078263"
        ]
      }
    ], 
    "publisher": {
      "name": "Springer Nature", 
      "type": "Organisation"
    }, 
    "sameAs": [
      "https://doi.org/10.1007/978-0-387-69222-7_2", 
      "https://app.dimensions.ai/details/publication/pub.1036846740"
    ], 
    "sdDataset": "chapters", 
    "sdDatePublished": "2022-01-01T19:08", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220101/entities/gbq_results/chapter/chapter_14.jsonl", 
    "type": "Chapter", 
    "url": "https://doi.org/10.1007/978-0-387-69222-7_2"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/978-0-387-69222-7_2'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/978-0-387-69222-7_2'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/978-0-387-69222-7_2'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/978-0-387-69222-7_2'


 

This table displays all metadata directly associated to this object as RDF triples.

149 TRIPLES      22 PREDICATES      81 URIs      73 LITERALS      11 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/978-0-387-69222-7_2 schema:about N6de8e8e5597040dfbe24854096e1fab7
2 Nedb17bedc9f44d92a783036aa5fc9456
3 Nfa07d7b76a074174a2529049afe793e8
4 anzsrc-for:11
5 anzsrc-for:1109
6 anzsrc-for:1112
7 schema:author N8b184891b2e9461bad89edc05cb88329
8 schema:datePublished 2007
9 schema:datePublishedReg 2007-01-01
10 schema:description Brain metastases represent a significant healthcare problem, with almost 200,000 patients in the United States annually suffering from symptomatic parenchymal lesions. Lung, breast, melanoma, renal, and gastrointestinal cancers make up most of the clinically relevant lesions. Although median survival once brain metastases are diagnosed is less than a year, timely therapy can restore neurological function and can prevent further neurological complications for the duration of a patient’s survival. Important prognostic features include absence of extracranial disease progression, young age, high pretreatment neurological status, a low number of lesions, and a long interval from primary disease diagnosis to the development of brain metastases.
11 schema:editor N5291f518db5d4e49add441c0b8645b22
12 schema:genre chapter
13 schema:isAccessibleForFree false
14 schema:isPartOf N1da2d491afd546ba892670952d278b46
15 schema:keywords United States
16 absence
17 age
18 brain metastases
19 breast
20 cancer
21 complications
22 development
23 diagnosis
24 disease diagnosis
25 disease progression
26 duration
27 economics
28 extracranial disease progression
29 features
30 function
31 further neurological complications
32 gastrointestinal cancer
33 healthcare problem
34 high pretreatment neurological status
35 important prognostic features
36 intervals
37 lesions
38 longer intervals
39 low number
40 lung
41 median survival
42 melanoma
43 metastasis
44 neurological complications
45 neurological function
46 neurological status
47 number
48 parenchymal lesions
49 patient survival
50 patients
51 pretreatment neurological status
52 primary disease diagnosis
53 problem
54 prognostic features
55 progression
56 relevant lesions
57 significant healthcare problem
58 state
59 status
60 survival
61 symptomatic parenchymal lesions
62 therapy
63 timely therapy
64 years
65 younger age
66 schema:name The Economics of Brain Metastases
67 schema:pagination 23-29
68 schema:productId N736862bb86304e469ec8b27c5790867c
69 Naf477d51884546e9bd67966b94fa0376
70 Nd14bfb4934824d53aa9b7f7363451f58
71 schema:publisher Nb38640c0ec1d450c8e9f5d76a00eed16
72 schema:sameAs https://app.dimensions.ai/details/publication/pub.1036846740
73 https://doi.org/10.1007/978-0-387-69222-7_2
74 schema:sdDatePublished 2022-01-01T19:08
75 schema:sdLicense https://scigraph.springernature.com/explorer/license/
76 schema:sdPublisher N16ff67737b654965b5aefd8144ec5860
77 schema:url https://doi.org/10.1007/978-0-387-69222-7_2
78 sgo:license sg:explorer/license/
79 sgo:sdDataset chapters
80 rdf:type schema:Chapter
81 N16ff67737b654965b5aefd8144ec5860 schema:name Springer Nature - SN SciGraph project
82 rdf:type schema:Organization
83 N1da2d491afd546ba892670952d278b46 schema:isbn 978-0-387-69221-0
84 978-0-387-69222-7
85 schema:name Brain Metastases
86 rdf:type schema:Book
87 N5291f518db5d4e49add441c0b8645b22 rdf:first Nbaa18d143457406b9235a2c0610f1f7f
88 rdf:rest N807d9ded129e4908bddbf7acd0ae346c
89 N6de8e8e5597040dfbe24854096e1fab7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
90 schema:name Humans
91 rdf:type schema:DefinedTerm
92 N736862bb86304e469ec8b27c5790867c schema:name pubmed_id
93 schema:value 18078263
94 rdf:type schema:PropertyValue
95 N807d9ded129e4908bddbf7acd0ae346c rdf:first Nabb560153d9d403ea4de034174465292
96 rdf:rest rdf:nil
97 N8b184891b2e9461bad89edc05cb88329 rdf:first sg:person.01100705232.37
98 rdf:rest Ncd4b49207f5c4983ae9fb4dc3c69adae
99 Nabb560153d9d403ea4de034174465292 schema:familyName Abrey
100 schema:givenName Lauren E.
101 rdf:type schema:Person
102 Nad2b9d143d8f411fad023d1e8898bbee rdf:first sg:person.01220574267.85
103 rdf:rest rdf:nil
104 Naf477d51884546e9bd67966b94fa0376 schema:name dimensions_id
105 schema:value pub.1036846740
106 rdf:type schema:PropertyValue
107 Nb38640c0ec1d450c8e9f5d76a00eed16 schema:name Springer Nature
108 rdf:type schema:Organisation
109 Nbaa18d143457406b9235a2c0610f1f7f schema:familyName Raizer
110 schema:givenName Jeffrey J.
111 rdf:type schema:Person
112 Ncd4b49207f5c4983ae9fb4dc3c69adae rdf:first sg:person.013156761617.16
113 rdf:rest Nad2b9d143d8f411fad023d1e8898bbee
114 Nd14bfb4934824d53aa9b7f7363451f58 schema:name doi
115 schema:value 10.1007/978-0-387-69222-7_2
116 rdf:type schema:PropertyValue
117 Nedb17bedc9f44d92a783036aa5fc9456 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
118 schema:name Radiosurgery
119 rdf:type schema:DefinedTerm
120 Nfa07d7b76a074174a2529049afe793e8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
121 schema:name Brain Neoplasms
122 rdf:type schema:DefinedTerm
123 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
124 schema:name Medical and Health Sciences
125 rdf:type schema:DefinedTerm
126 anzsrc-for:1109 schema:inDefinedTermSet anzsrc-for:
127 schema:name Neurosciences
128 rdf:type schema:DefinedTerm
129 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
130 schema:name Oncology and Carcinogenesis
131 rdf:type schema:DefinedTerm
132 sg:person.01100705232.37 schema:affiliation grid-institutes:grid.16753.36
133 schema:familyName Bennett
134 schema:givenName Charles L.
135 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01100705232.37
136 rdf:type schema:Person
137 sg:person.01220574267.85 schema:affiliation grid-institutes:grid.16753.36
138 schema:familyName Fitzner
139 schema:givenName Karen A.
140 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01220574267.85
141 rdf:type schema:Person
142 sg:person.013156761617.16 schema:affiliation grid-institutes:grid.16753.36
143 schema:familyName Tigue
144 schema:givenName Cara C.
145 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013156761617.16
146 rdf:type schema:Person
147 grid-institutes:grid.16753.36 schema:alternateName Division of Hematology/Oncology Feinberg School of Medicine The Robert H. Lurie Comprehensive Cancer Center, Northwestern University, 60611, Chicago, IL, USA
148 schema:name Division of Hematology/Oncology Feinberg School of Medicine The Robert H. Lurie Comprehensive Cancer Center, Northwestern University, 60611, Chicago, IL, USA
149 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...